Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008

d findings from an OSU clinical study that indicated that a

SELDI-TOF-based TTP diagnostic test, which already has been

commercially launched as a laboratory developed test by the

institution, also could be used to help estimate the risk of TTP

relapses during clinical remission. The data -- published in the

online edition of the British Journal of Haematology -- indicate

that use of the test may provide a novel screening strategy to

identify patients who may benefit from prophylactic treatment to

help prevent relapse of this serious blood disorder.

-- Corporate Developments

* Appointed John F. Hamilton, former vice president and chief

financial officer of Depomed, Inc., to the Vermillion Board of

Directors and to serve as chairman of the Audit Committee of the

Board.

* Received issuance of U.S. Patent No. 7,341,838 for the discovery of

novel forms of brain natriuretic peptide (BNP), which could

potentially improve upon the current standard of care in diagnosing

and treating cardiovascular disease. The discovery could ultimately

lead to the development of an improved, next-generation assay that

might provide physicians with additional, valuable information to

stratify patients at risk for cardiovascular disease.

* Renewed a long-standing collaboration with Johns Hopkins University

on the development of novel biomarkers that can be applied toward

disease detection, classification and monitoring of prevalent

cancers, including ovarian, breast and prostate. Vermillion will

have access to exclusive commercial rights to the discoveries made

through the partnership.

* Vermillion's stockholders and board of directors approved a 1 for


'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... 2015 , ... PRC Clinical, a Clinical Trial Management Expert CRO, ... in southern California. The Clinical Trial Management Expert CRO seeks to introduce more California-based ... , Stem Cell Meeting on the Mesa on October ...
(Date:8/25/2015)... SHANGHAI , Aug. 25, 2015   WuXi ... open-access R&D capability and technology platform company serving the ... Holdings Ltd. ("Lee,s Pharm," Hong Kong Exchange Stock Code: ... Hong Kong with 20 years of operations ... the two companies have signed an agreement whereby WuXi,s ...
(Date:8/25/2015)... ... August 25, 2015 , ... ... facility in Knapp, Wis. The company has added a AS16 Sharples centrifuge to ... data collection during bacterial or fungal fermentation process development. , The new ...
(Date:8/25/2015)... ... August 25, 2015 , ... One of the world’s ... Resilinc Corp., Bindiya Vakil, has been on a mission for the past two ... global supply chain operations - from the two massive explosions that occurred on August ...
Breaking Biology Technology:PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3New centrifuge and fermentor expand product development capacity at Vets Plus 2Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 2Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 3Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 4
... Jan. 30 AMDL, Inc. (Amex:,ADL), headquartered ... and Jilin, China, through its wholly owned ... biopharma company that,together with JPI, engages in ... health care and diagnostic products. The,Company announced ...
... --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) (,China-Biotics", ... the manufacture,research, development, marketing and distribution of ... new bilingual corporate Web site under,the domain ... The new Web site was created to ...
... AVIV, Israel, January 30 TopSpin Medical,Inc. (TASE: ... MRI System at ZOL Hospital, Genk, Belgium,with the ... are pleased to be the first site to ... represents a major breakthrough,in our ability to detect ...
Cached Biology Technology:AMDL Wins Chinese Military Supply Agreement for Its Domperidone Product for up to $6.6 Million 2China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site 2Topspin Medical Announces First Commercial Installation of the Cathamaran(TM) Intravascular MRI System 2Topspin Medical Announces First Commercial Installation of the Cathamaran(TM) Intravascular MRI System 3
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/31/2015)... -- The 10 th International Conference on Genomics (ICG-10, ... 2015, in Shenzhen , China ... th anniversary this year. Since its inauguration in 2006, ... meetings in the ,omics, fields, and is one of the ... ICG-10 focuses on recent breakthroughs and advances in ,omics, research ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... This release is available in German . ... interglacial epoch, around 115,000 years ago, there were significant ... transition from the Eemian Interglacial to the Weichselian Glacial ... with possibly at least two warming events. This is ...
... Sergiu M. Gorun, PhD, associate professor of chemistry ... www.njit.edu , was awarded a patent today for ... Compositions of Perfluoroalkyl Perfluoro-Phthalocyanine Compounds" (US Patent Number ... These new materials are comprised of organic ...
... Blacksburg, Va. A scientific paper that describes a ... biological processes has exceeded 500 citations in the ISI ... the impact of scientific publications. The Systems Biology Markup ... quantitative models of biochemical networks between different computer software ...
Cached Biology News:Were short warm periods typical for transitions between interglacial and glacial epochs? 2NJIT researcher awarded patent for hydrophobic, corrosion-resistant coating 2After 5 years, free systems biology markup language has proven popular 2After 5 years, free systems biology markup language has proven popular 3